[7, 8] Because the WBC count and the fractions of each of the WBC types and the CRP level are indicators of systemic inflammation and immune responses, these counts, ratios, or levels may be good candidate biomarkers for predicting aggressive cancer. This evidence concerns the gene CRP and cancer.